Fingerprint
Dive into the research topics of 'Estimating the population benefits and costs of Rituximab therapy in the United States from 1998 to 2013 using real-world data'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Estimating the population benefits and costs of Rituximab therapy in the United States from 1998 to 2013 using real-world data
Mark D. Danese, Carolina M. Reyes, Michelle L. Gleeson, Marc Halperin, Sandra L. Skettino, Joseph Mikhael
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations